Skip to main content
SpringerLink
Log in
Book cover

Sickle Cell Anemia pp 285–318Cite as

Clinical Manifestations and Treatment of Adult Sickle Cell Disease

  • Chapter
  • First Online:

Abstract

Despite being a disease that stems primarily from abnormalities in the erythrocytes, clinical manifestations and complications of sickle cell disease are known to affect virtually all organs and systems in the human body. Chronic hemolytic anemia and a systemic inflammatory state are the basic pathophysiological mechanisms that underlie the occurrence of both acute vaso-occlusive events (painful episodes, acute chest syndrome, priapism, stroke, etc.) and long-term end-organ damage (heart failure, chronic kidney disease, retinopathy, pulmonary hypertension, leg ulcers, osteoporosis, etc.). Adequate treatment for sickle cell disease in children with vaccination and prophylactic penicillin has allowed most of these patients to reach adulthood. Nevertheless, morbidity in the adult population is high, with many patients presenting with two or more vital organ complications by the age of 40. There is still room for improvement in the prevention, early diagnosis, and treatment of complications more frequently encountered by adult hematologists, and need for consultation with other subspecialties becomes a rule when caring for adult sickle cell patients. We review the clinical presentation, diagnosis, and management of the most relevant aspects of sickle cell disease in adults and summarize current treatment approaches, from supportive care with blood transfusions and hydroxyurea, to curative care with hematopoietic stem cell transplantation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Adams RJ, McKie VC, Hsu L et al (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339(1):5–11

    Article  CAS  PubMed  Google Scholar 

  • Adewoye AH, Chen TC, Ma Q et al (2008) Sickle cell bone disease: response to vitamin D and calcium. Am J Hematol 83(4):271–274

    Article  CAS  PubMed  Google Scholar 

  • Ahn H, Li CS, Wang W (2005) Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatr Blood Cancer 45(2):184–190

    Article  PubMed  Google Scholar 

  • Al Omran A (2013) Multiple drilling compared with standard core decompression for avascular necrosis of the femoral head in sickle cell disease patients. Arch Orthop Trauma Surg 133(5):609–613

    Article  PubMed  Google Scholar 

  • Arlet JB, Courbebaisse M, Chatellier G et al (2013) Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults. Bone 52(1):206–211

    Article  CAS  PubMed  Google Scholar 

  • Ataga KI, Klings ES (2014) Pulmonary hypertension in sickle cell disease: diagnosis and management. Hematology Am Soc Hematol Educ Program 2014(1):425–431

    Article  PubMed  Google Scholar 

  • Baldanzi G, Traina F, Neto JFM et al (2011) Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease. Clinics 66(5):801–805

    Article  PubMed  PubMed Central  Google Scholar 

  • Ballas SK, Baxter JK, Riddick G (2006) Folate supplementation and twinning in patients with sickle cell disease. Am J Hematol 81(4):296–297

    Article  PubMed  Google Scholar 

  • Bernaudin F, Socie G, Kuentz M et al (2007) Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 110(7):2749–2756

    Article  CAS  PubMed  Google Scholar 

  • Bernaudin F, Verlhac S, Arnaud C et al (2015) Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia. Blood 125(10):1653–1661

    Article  CAS  PubMed  Google Scholar 

  • Berry PA, Cross TJ, Thein SL et al (2007) Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol 5(12):1469–1476

    Article  PubMed  Google Scholar 

  • Bijur PE, Latimer CT, Gallagher EJ (2003) Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med 10(4):390–392

    Article  PubMed  Google Scholar 

  • Bolaños-Meade J, Fuchs EJ, Luznik L et al (2012) HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 120(22):4285–4291

    Article  PubMed  PubMed Central  Google Scholar 

  • Brodsky RA, Luznik L, Bolaños-Meade J et al (2008) Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant 42(8):523–527

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Burnett AL, Anele UA, Trueheart IN, Strouse JJ, Casella JF (2014) Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am J Med 127(7):664–668

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Caldas MC, Meira ZA, Barbosa MM (2008) Evaluation of 107 patients with sickle cell anemia through tissue Doppler and myocardial performance index. J Am Soc Echocardiogr 21(10):1163–1167

    Article  PubMed  Google Scholar 

  • Calvet D, Bernaudin F, Gueguen A et al (2015) First ischemic stroke in sickle-cell disease: are there any adult specificities? Stroke 46(8):2315–2317

    Article  CAS  PubMed  Google Scholar 

  • Cappelli B, Bernaudin F, Ruggeri A et al (2015) Hematopoietic stem cell transplantation from HLA identical sibling for sickle cell disease an international survey on behalf of eurocord-Monacord, EBMT paediatric disease working party and CIBMTR. Blood 126(23):541

    Google Scholar 

  • Chaine B, Neonato MG, Girot R, Aractingi S (2001) Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol 137(4):467–470

    Google Scholar 

  • Charache S, Dover GJ, Moyer MA, Moore JW (1987) Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood 69(1):109–116

    CAS  PubMed  Google Scholar 

  • Charache S, Terrin ML, Moore RD et al (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332(20):1317–1322

    Article  CAS  PubMed  Google Scholar 

  • Charache S, Barton FB, Moore RD et al (1996) Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) 75(6):300–326

    Article  CAS  Google Scholar 

  • Clarke HJ, Jinnah RH, Brooker AF, Michaelson JD (1989) Total replacement of the hip for avascular necrosis in sickle cell disease. J Bone Joint Surg Br 71(3):465–470

    CAS  PubMed  Google Scholar 

  • Colombatti R, Varotto E, Ricato S et al (2011) Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation. Hematol Rep 3(2):e12

    Article  PubMed  PubMed Central  Google Scholar 

  • Costabile RA (1998) Successful treatment of stutter priapism with an antiandrogen. Tech Urol 4(3):167–168

    CAS  PubMed  Google Scholar 

  • de Montalembert M, Maunoury C, Acar P et al (2004) Myocardial ischaemia in children with sickle cell disease. Arch Dis Child 89(4):359–362

    Article  PubMed  PubMed Central  Google Scholar 

  • DeBaun MR, Armstrong FD, McKinstry RC et al (2012) Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 119(20):4587–4596

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dhar M, Bellevue R, Carmel R (2003) Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation. N Engl J Med 348(22):2204–2207

    Article  PubMed  Google Scholar 

  • Diav-Citrin O, Hunnisett L, Sher GD, Koren G (1999) Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature. Am J Hematol 60(2):148–150

    Article  CAS  PubMed  Google Scholar 

  • Fattori A, de Souza RA, Saad ST, Costa FF (2005) Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment. Hematol J 5(7):589–590

    Article  PubMed  Google Scholar 

  • Fitzhugh CD, Lauder N, Jonassaint JC et al (2010) Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol 85(1):36–40

    PubMed  Google Scholar 

  • Fonseca GH, Souza R, Salemi VM, Jardim CV, Gualandro SF (2012) Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur Respir J 39(1):112–118

    Article  CAS  PubMed  Google Scholar 

  • Gardner K, Suddle A, Kane P et al (2014) How we treat sickle hepatopathy and liver transplantation in adults. Blood 123(15):2302–2307

    Article  CAS  PubMed  Google Scholar 

  • Garozzo G, Disca S, Fidone C, Bonomo P (2000) Azoospermia in a patient with sickle cell disease treated with hydroxyurea. Haematologica 85(11):1216–1218

    CAS  PubMed  Google Scholar 

  • Gbadoé AD, Atakouma Y, Kusiaku K, Assimadi JK (2001) Management of sickle cell priapism with etilefrine. Arch Dis Child 85(1):52–53

    Article  PubMed  PubMed Central  Google Scholar 

  • Gillette PN, Manning JM, Cerami A (1971) Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate. Proc Natl Acad Sci U S A 68(11):2791–2793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gladwin MT, Sachdev V, Jison ML et al (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350(9):886–895

    Article  CAS  PubMed  Google Scholar 

  • Goldberg MF (1971) Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol 71(3):649–665

    Article  CAS  PubMed  Google Scholar 

  • Gueguen A, Mahevas M, Nzouakou R et al (2014) Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center. Am J Hematol 89(3):267–272

    Article  PubMed  Google Scholar 

  • Hernigou P, Habibi A, Bachir D, Galacteros F (2006) The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am 88(12):2565–2572

    Article  PubMed  Google Scholar 

  • Hernigou P, Daltro G, Filippini P, Mukasa MM, Manicom O (2008a) Percutaneous implantation of autologous bone marrow osteoprogenitor cells as treatment of bone avascular necrosis related to sickle cell disease. Open Orthop J 2:62–65

    Article  PubMed  PubMed Central  Google Scholar 

  • Hernigou P, Zilber S, Filippini P et al (2008b) Total THA in adult osteonecrosis related to sickle cell disease. Clin Orthop Relat Res 466(2):300–308

    Article  PubMed  PubMed Central  Google Scholar 

  • Hernigou P, Poignard A, Zilber S, Rouard H (2009) Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop 43(1):40–45

    Article  PubMed  PubMed Central  Google Scholar 

  • Hoeh MP, Levine LA (2014) Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. J Sex Med 11(1):197–204

    Article  CAS  PubMed  Google Scholar 

  • Hoeper MM, Bogaard HJ, Condliffe R et al (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D42–D50

    Article  PubMed  Google Scholar 

  • Horwitz ME, Spasojevic I, Morris A et al (2007) Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. Biol Blood Marrow Transplant 13(12):1422–1426

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Howard J, Hart N, Roberts-Harewood M et al (2015) Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol 169(4):492–505

    Article  PubMed  Google Scholar 

  • Hsieh MM, Fitzhugh CD, Weitzel RP et al (2014) Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA 312(1):48–56

    Article  PubMed  PubMed Central  Google Scholar 

  • Hulbert ML, McKinstry RC, Lacey JL et al (2011) Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood 117(3):772–779

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jacobsohn DA, Duerst R, Tse W, Kletzel M (2004) Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 364(9429):156–162

    Article  PubMed  Google Scholar 

  • Kassim AA, DeBaun MR (2013) Sickle cell disease, vasculopathy, and therapeutics. Annu Rev Med 64:451–466

    Article  CAS  PubMed  Google Scholar 

  • Koshy M, Burd L, Wallace D, Moawad A, Baron J (1988) Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. N Engl J Med 319(22):1447–1452

    Article  CAS  PubMed  Google Scholar 

  • Krishnamurti L, Sullivan KM, Kamani NR et al (2015) Results of a multicenter pilot investigation of bone marrow transplantation in adults with sickle cell disease (STRIDE). Blood 126(23):543

    Google Scholar 

  • Kugler S, Anderson B, Cross D et al (1993) Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. Arch Neurol 50(6):629–635

    Google Scholar 

  • Lanzkron S, Strouse JJ, Wilson R et al (2008) Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 148(12):939–955

    Article  PubMed  PubMed Central  Google Scholar 

  • Lima CS, Ueti OM, Ueti AA et al (2008) Enalapril therapy and cardiac remodelling in sickle cell disease patients. Acta Cardiol 63(5):599–602

    Article  PubMed  Google Scholar 

  • Lopes FC, Traina F, Almeida CB et al (2015) Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea. Haematologica 100(6):730–739

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mackin RS, Insel P, Truran D et al (2014) Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology 82(10):835–841

    Article  PubMed  PubMed Central  Google Scholar 

  • Malinowski AK, Shehata N, D'Souza R et al (2015) Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis. Blood 126(21):2424-35

    Google Scholar 

  • Mantadakis E, Ewalt DH, Cavender JD, Rogers ZR, Buchanan GR (2000) Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 95(1):78–82

    Google Scholar 

  • Matthes-Martin S, Lawitschka A, Fritsch G et al (2013) Stem cell transplantation after reduced-intensity conditioning for sickle cell disease. Eur J Haematol 90(4):308–312

    Article  PubMed  Google Scholar 

  • Milner PF, Kraus AP, Sebes JI et al (1991) Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 325(21):1476–1481

    Article  CAS  PubMed  Google Scholar 

  • Milner PF, Kraus AP, Sebes JI et al (1993) Osteonecrosis of the humeral head in sickle cell disease. Clin Orthop Relat Res 289:136–143

    PubMed  Google Scholar 

  • Minniti CP, Gorbach AM, Xu D et al (2014) Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trial. Lancet Haematol 1(3):e95–e103

    Article  PubMed  PubMed Central  Google Scholar 

  • Mont MA, Zywiel MG, Marker DR, McGrath MS, Delanois RE (2010) The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am 92(12):2165–2170

    Article  PubMed  Google Scholar 

  • Montague DK, Jarow J, Broderick GA et al (2003) American Urological Association guideline on the management of priapism. J Urol 170(4 Pt 1):1318–1324

    Article  PubMed  Google Scholar 

  • Mukisi-Mukaza M, Elbaz A, Samuel-Leborgne Y et al (2000) Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease. Orthopedics 23(4):357–363

    CAS  PubMed  Google Scholar 

  • Myrvik MP, Drendel AL, Brandow AM et al (2015) A comparison of pain assessment measures in pediatric sickle cell disease: visual analog scale versus numeric rating scale. J Pediatr Hematol Oncol 37:190–194

    Article  PubMed  Google Scholar 

  • Nagel RL, Fabry ME, Steinberg MH (2003) The paradox of hemoglobin SC disease. Blood Rev 17(3):167–178

    Article  PubMed  Google Scholar 

  • Neumayr LD, Aguilar C, Earles AN et al (2006) Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am 88(12):2573–2582

    Article  PubMed  Google Scholar 

  • Norris WE (2004) Acute hepatic sequestration in sickle cell disease. J Natl Med Assoc 96(9):1235–1239

    PubMed  PubMed Central  Google Scholar 

  • Ohene-Frempong K, Weiner SJ, Sleeper LA et al (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91(1):288–294

    CAS  PubMed  Google Scholar 

  • Okomo U, Meremikwu MM (2012) Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database Syst Rev 6, CD005406

    PubMed  Google Scholar 

  • Panepinto JA, Walters MC, Carreras J et al (2007) Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 137(5):479–485

    Article  PubMed  Google Scholar 

  • Patrick PA, Rosenthal BM, Iezzi CA, Brand DA (2015) Timely pain management in the emergency department. J Emerg Med 48(3):267–273

    Article  PubMed  Google Scholar 

  • Platt OS, Thorington BD, Brambilla DJ et al (1991) Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325(1):11–16

    Article  CAS  PubMed  Google Scholar 

  • Poignard A, Flouzat-Lachaniette CH, Amzallag J, Galacteros F, Hernigou P (2012) The natural progression of symptomatic humeral head osteonecrosis in adults with sickle cell disease. J Bone Joint Surg Am 94(2):156–162

    Article  PubMed  Google Scholar 

  • Porter J, Garbowski M (2013) Consequences and management of iron overload in sickle cell disease. Hematology Am Soc Hematol Educ Program 2013:447–456

    Article  PubMed  Google Scholar 

  • Rabb LM, Grandison Y, Mason K et al (1983) A trial of folate supplementation in children with homozygous sickle cell disease. Br J Haematol 54(4):589–594

    Article  CAS  PubMed  Google Scholar 

  • Sachdev V, Machado RF, Shizukuda Y et al (2007) Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol 49(4):472–479

    Article  PubMed  PubMed Central  Google Scholar 

  • Sarrai M, Duroseau H, D’Augustine J, Moktan S, Bellevue R (2007) Bone mass density in adults with sickle cell disease. Br J Haematol 136(4):666–672

    Article  CAS  PubMed  Google Scholar 

  • Sauter C, Rausen AR, Barker JN (2010) Successful unrelated donor cord blood transplantation for adult sickle cell disease and Hodgkin lymphoma. Bone Marrow Transplant 45(7):1252

    Article  CAS  PubMed  Google Scholar 

  • Schnog JB, van der Dijs FP, Brouwer DA et al (2000) Plasma homocysteine levels in sickle cell disease and the need for folate supplementation. J Pediatr Hematol Oncol 22(2):184–185, author reply 185–186

    Article  CAS  PubMed  Google Scholar 

  • Serjeant GR, Galloway RE, Gueri MC (1970) Oral zinc sulphate in sickle-cell ulcers. Lancet 2(7679):891–892

    Article  CAS  PubMed  Google Scholar 

  • Serjeant GR, de Ceulaer K, Maude GH (1985) Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 2(8467):1274–1276

    Article  CAS  PubMed  Google Scholar 

  • Sharma S, Efird JT, Knupp C et al (2015) Sleep disorders in adult sickle cell patients. J Clin Sleep Med 11(3):219–223

    PubMed  PubMed Central  Google Scholar 

  • Sharpe CC, Thein SL (2011) Sickle cell nephropathy – a practical approach. Br J Haematol 155(3):287–297

    Article  CAS  PubMed  Google Scholar 

  • Sharpe CC, Thein SL (2014) How I treat renal complications in sickle cell disease. Blood 123(24):3720–3726

    Article  CAS  PubMed  Google Scholar 

  • Silva GS, Vicari P, Figueiredo MS et al (2009) Brain magnetic resonance imaging abnormalities in adult patients with sickle cell disease: correlation with transcranial Doppler findings. Stroke 40(7):2408–2412

    Article  PubMed  Google Scholar 

  • Simmer K, Iles CA, James C, Thompson RP (1987) Are iron-folate supplements harmful? Am J Clin Nutr 45(1):122–125

    CAS  PubMed  Google Scholar 

  • Steinberg ME, Hayken GD, Steinberg DR (1995) A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 77(1):34–41

    CAS  PubMed  Google Scholar 

  • Stoica Z, Dumitrescu D, Popescu M et al (2009) Imaging of avascular necrosis of femoral head: familiar methods and newer trends. Curr Health Sci J 35(1):23–28

    PubMed  PubMed Central  Google Scholar 

  • Vichinsky EP, Neumayr LD, Gold JI et al (2010) Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 303(18):1823–1831

    Article  PubMed  PubMed Central  Google Scholar 

  • Voskaridou E, Christoulas D, Terpos E (2012) Sickle-cell disease and the heart: review of the current literature. Br J Haematol 157(6):664–673

    Article  CAS  PubMed  Google Scholar 

  • Wethers DL, Ramirez GM, Koshy M et al (1994) Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group. Blood 84(6):1775–1779

    CAS  PubMed  Google Scholar 

  • Yawn BP, Buchanan GR, Afenyi-Annan AN et al (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312(10):1033–1048

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology Center, School of Medical Sciences, University of Campinas – UNICAMP, Campinas, São Paulo, Brazil

    Fernando Ferreira Costa MD, PhD

  2. Department of Clinical Pathology, School of Medical Sciences, University of Campinas – UNICAMP, Campinas, São Paulo, Brazil

    Kleber Yotsumoto Fertrin MD, PhD

Authors
  1. Fernando Ferreira Costa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kleber Yotsumoto Fertrin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fernando Ferreira Costa MD, PhD .

Editor information

Editors and Affiliations

  1. Centro de Hematologia e Hemoterapia, Unicamp, Campinas, São Paulo, Brazil

    Fernando Ferreira Costa

  2. Centro de Hematologia e Hemoterapia, Unicamp, Campinas, São Paulo, Brazil

    Nicola Conran

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Costa, F.F., Fertrin, K.Y. (2016). Clinical Manifestations and Treatment of Adult Sickle Cell Disease. In: Costa, F., Conran, N. (eds) Sickle Cell Anemia. Springer, Cham. https://doi.org/10.1007/978-3-319-06713-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-06713-1_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-06712-4

  • Online ISBN: 978-3-319-06713-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation